A man receives the first dose of the AstraZeneca COVID-19 vaccine at a private medical office, in Paris.
Christophe Petit Tesson/EFA-EPE
Stockpiles of this vaccine are going unused in France and Germany, and unfounded criticism of it may be partly to blame.
Peter Byrne/PA
Medical decision-making is often based on universal principles of fairness. But what happens when systemic racism means the dice are rigged to begin with?
There’s a case for targeting vaccine rollout on areas where healthy life expectancy is low, such as Blackpool.
Ian Walsh/Shutterstock
For those who are socially deprived, vulnerability to COVID-19 will arise at an earlier age.
EPA/Fabio Frustaci
Much has changed in the year since the nation became the first in Europe to be hit by the pandemic.
Rich Carey/Shutterstock
By continuing to privilege economic growth over environmental and social sustainability, we are taking huge risks with our future.
DisobeyArt/Shutterstock
The Conversation is bringing together three experts in human behaviour for an online discussion about how this virus has changed us, and how long the effects might last.
How long will protection last?
JL / Alamy Stock Photo
Immunity fades rapidly for some infections (influenza) but lasts a lifetime with others (measles). Here’s what we know about COVID.
Vaccine developers working at a BioNTech facility.
BioNTech/EPA-EFE
With multiple variants of concern now present in the UK, attention is turning to when updated vaccines for them will be ready.
By early March only one-third of Germany’s stocks of the Oxford/AstraZeneca vaccine had been used – possibly because of misinformation about its effects.
Sean Gallup/EPA-EFE
Fears that the vaccine doesn’t work in older people appear unfounded.
Facundo Arrizabalaga/EPA
In a pandemic that exacerbates the gap between rich and poor, was the UK always doomed to have an enormous death toll?
kitchen / Alamy Stock Photo
The real concern is if two variants infect the same cell and swap genetic material.
Clinicians prepare to give vaccinations in Salisbury Cathedral.
EPA/Neil Hall
Governments are naturally under pressure to focus on national rollouts. But the truth is none of us is safe until we’re all safe.
Surge testing unit in South Gloucestershire, England.
Andrew Lloyd / Alamy Stock Photo
The P1 variant has arrived in the UK, with early analysis suggesting it may be more transmissible and able to partially escape existing immunity.
Problems inside problems inside problems.
Evgeni Tcherkasski/Unsplash
One year on from when lockdowns began in the west, specialists reflect on how these two fields have responded to the crisis.
Israel has the highest rate of COVID-19 vaccine coverage worldwide, and so has been one of the first countries to report on vaccine effectiveness.
Abir Sultan/EPA-EFE
Real-world studies of vaccines aren’t directly comparable with clinical trials, but their results are still good news.
LittleDogKorat/Shutterstock
There will be lessons we can learn for the future of childbearing once the pandemic is over.
shutterstock.
Rashes and lesions are a potentially useful way of spotting COVID-19 patients who are otherwise asymptomatic.
Velishchuk Yevhen/Shutterstock
Perhaps we should rethink how we monitor pregnant women who have COVID.
Proportionally, twice as many white people in eligible categories have received a dose of a COVID vaccine than people from BAME groups.
EPA-EFE/Neil Hall
Reluctance to take the vaccine may not be as unique to Black and Asian communities as it seems
Coronavirus samples sit in an ice bucket ready to be sequenced and analysed.
REUTERS / Alamy Stock Photo
B1525 is a new coronavirus variant under investigation by Public Health England.